Center of Excellence Discussion Series and Engagement

The Center of Excellence engages and collaborates with outsourcing facilities, compounders and other stakeholders to improve the overall quality of compounded drugs in support of section 503B of the Food, Drug, and Cosmetic Act. The Center of Excellence provides opportunities for FDA to engage with and support the outsourcing facility sector through training, meetings, research, and an annual conference. This contract will help increase engagement with the Center of Excellence and allow FDA to notify outsourcing facilities and other stakeholders about these opportunities. Excellent communication and ongoing engagement is essential to the success of the Center of Excellence.